The removal did not resolve the underlying safety questions
The younger the unborn child, the more problematic the bacteriostatic used in medication would be
doi: 10.3390/ijms23020739 Summary Keywords metabolic reprogramming, glucagon-like peptide-1 receptor agonists, heart failure, cardiovascular system, diabetes Citation Wang X, Qi M, Yang L, Yang L, Wang X, Zhang F, Cui Y, Wang D, Wang Y and Lv W (2025) GLP-1 receptor agonists synergistic effects of metabolic reprogramming and cardioprotection
However, if you do experience this, then you might be taking a dose that is too high for you, and you can try lowering it
doi:10.1007/s10803-015-2628-xCrossRefGoogle ScholarPubMed Gupta, M, Hoover, G
GLP-1 activates K ATP channels in coronary pericytes as the effector of brain-gut-heart signalling mediating cardioprotection